Product Details

Verified Reactivity

Human

Reported Reactivity

African Green, Baboon, Cynomolgus, Rhesus

Antibody Type

Monoclonal

Host Species

Mouse

Immunogen

CCR7-transfected cells

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)

Preparation

The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions.

Concentration

Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Excitation Laser

Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)

Product Citations

1. Aschmoneit N, et al. 2021. J Immunother Cancer. 9:. PubMed
2. Rendeiro AF, et al. 2020. Nat Commun. 11:577. PubMed
3. Li M, et al. 2022. Sci Rep. 12:378. PubMed
4. Zeng W, et al. 2017. Front Immunol. 0.806944444. PubMed
5. Zhou R, et al. 2020. Immunity. S1074-7613(20)30333-2.. PubMed
6. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
7. Kubo M, et al. 2018. Oncol Rep. 39:417. PubMed
8. Kramer KJ, et al. 2022. Nat Commun. 13:3466. PubMed
9. Xiong X, et al. 2021. Liver Int. 41:1033. PubMed
10. Cappellano G, et al. 2018. PLoS One. 13:e0192108. PubMed
11. Kang L, et al. 2020. Exp Hematol Oncol. 9:11. PubMed
12. Tatovic D, et al. 2015. J Immunol. 195: 386 - 392. PubMed
13. Zhang X, et al. 2021. Nat Commun. 12:5291. PubMed
14. Gullà A, et al. 2021. Cancer Discov. . PubMed
15. Aschmoneit N, et al. 2022. Oncoimmunology. 11:2028961. PubMed
16. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
17. Kuo HH, et al. 2018. Immunity. 48:1183. PubMed
18. Alhaj Hussen K, et al. 2017. Immunity. 47:680. PubMed
19. Ahmad S,et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. . 10.1016/j.pnpbp.2017.10.001. PubMed
20. Wu J et al. 2019. Immunity. 50(5):1218-1231 . PubMed
21. Magri G et al. 2017. Immunity. 47(1):118-134 . PubMed
22. Aschmoneit N, et al. 2021. Sci Rep. 11:13880. PubMed
23. Vadrevu KM, et al. 2022. Sci Rep. 12:12038. PubMed
24. Borowicz S, et al. 2021. PLOS ONE. 16(6):e0252197. PubMed
25. Usmani SM et al. 2019. Cell host & microbe. 25(1):73-86 . PubMed
26. Christiansen M, et al. 2020. Front Immunol. 10:3022. PubMed
27. Tavira B, et al. 2018. J Diabetes Res. 2018:9391845. PubMed
28. Audigé A, et al. 2017. BMC Immunology. 10.1186/s12865-017-0209-9. PubMed
29. Ramos MIP, et al. 2021. Elife. 10:. PubMed
30. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
31. Collins PL et al. 2018. Cell. 176(1-2):348-360 . PubMed
32. Chen Y, et al. 2020. Cell. 1496:183. PubMed
33. Montel‐Hagen A et al. 2019. Cell stem cell. 24(3):376-389 . PubMed
34. Gullà A, et al. 2021. Cancer Discov. 2:468. PubMed
35. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
36. Gamradt S, et al. 2021. iScience. 24:103312. PubMed

RRID

AB_10916391 (BioLegend Cat. No. 353203) AB_10913813 (BioLegend Cat. No. 353204)